Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
We have observed that chemotherapy agents can induce RNA degradation in tumour cells, a phenomenon called RNA disruption. Interestingly, we also found that high tumour RNA disruption after 2-3 cycles of chemotherapy predicts for complete tumour destruction after treatment and improved cancer patient survival. We and Rna Diagnostics, Inc. are using this knowledge to identify patients with non-responding tumours early in treatment, who might benefit from discontinuing chemotherapy (and its side effects) and moving on to alternate treatments. We now seek to identify earlier events in the RNA disruption process in order to accelerate our ability to predict chemotherapy outcome. The student will examine whether ubiquitination of ribosomal proteins and the activation of two key RNA degradation pathways precedes and are necessary for chemotherapy-dependent RNA disruption.
Tom Kovala
RNA Diagnostics Inc
Life Sciences
Health and Related Sciences & Technology; Professional, scientific and technical services
Laurentian University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.